The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

TearLab Corporation

  • TLB
  • TSX
  • Consumer Products
  • Latest 5.10
  • Currency C$
  • Change -0.53
  • Percent Change -9.414 %
  • Volume 6,600
  • Thu Apr 17, 2014 04:21 PM EDT TSX data delayed 15 minutes.
  • Open 5.33
  • Previous Close 5.63
  • High 5.33
  • Low 5.10
  • Bidx700 5.10
  • Askx600 5.50
  • 52-week High07/25 15.30
  • 52-week Low04/17 5.10
  • Beta 1.401
  • Market Cap 167.86M
  • EPS -0.96
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Press Releases

Financials & Calendars

Income Statement

  • Sales $11,847,000
  • Earnings $-28,491,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash --
  • Current Ratio 3.72

12 months ended Sep 30, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $53,481,000
  • Liabilities $12,573,000
  • Liabilities-to-Equity Ratio 0.31

Price Ratios

  • Price to Sales 13.74
  • Price to Book 3.95
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Mar 24 $-0.13 May 8 $-0.14
Surprises Nov 11 -14.29% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 17, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

TEARLAB CORPORATION is a a healthcare company focused on an ophthalmic device for the diagnosis and treatment of dry eye disease.

Related Securities
Symbol Type Latest % Chg

Officers

  • Elias Vamvakas C.E.O.
  • William Dumencu C.F.O. & Treasurer
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 27
  • Incorporation: United States,
    Jun 17, 2002
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

9980 Huennekens St., Suite 100
San Diego, CA

Phone: (858)-455-6006
Fax: (858)-8120540

bdumencu@tearlab.com
www.tearlab.com

Ideas & Discussion

Live Discussion of TLB on StockTwits